GluN2C/D Subunit Selective Antagonists of the N-Methyl-D-Aspartate Receptor
US-2024294493-A1 · Sep 5, 2024 · US
US9315449B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9315449-B2 |
| Application number | US-94552210-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 12, 2010 |
| Priority date | May 15, 2008 |
| Publication date | Apr 19, 2016 |
| Grant date | Apr 19, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to substituted pyrazole compounds, methods for their discovery, and their research and therapeutic uses, and pharmaceutical Formulations thereof. In particular, the present invention provides substituted pyrazole compounds capable of facilitating HSF1 homotrimerization, and methods of using such compounds as therapeutic agents to treat a number of conditions associated with irregular HSF1 activity.
Opening claim text (preview).
We claim: 1. A compound selected from the group consisting of:
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Drugs for disorders of the cardiovascular system · CPC title
Ophthalmic agents · CPC title
Drugs for disorders of the nervous system · CPC title
for treating abnormal movements, e.g. chorea, dyskinesia · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.